Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 238,263,140 papers from all fields of science
Search
Sign In
Create Free Account
Gilenya
Known as:
Gilenia
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
4 relations
Broader (2)
fingolimod
fingolimod hydrochloride
fingolimod 0.5 MG Oral Capsule [Gilenya]
fingolimod Oral Capsule [Gilenya]
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2013
2013
[The experience of using fingolimod (gilenya) in patients with relapsing-remitting multiple sclerosis].
Kotov Sv
,
Fedorova Si
,
Iakushina Ti
,
Lizhdvoĭ VIu
2013
Corpus ID: 69099565
: We present the results of a one-year follow-up study of 11 patients treated with gilenya. The results of cardiomonitoring (ECG…
Expand
2013
2013
Progressive multifocal leukoencephalopathy in a patient taking the MS pill Gilenya.
Clinical Infectious Diseases
2013
Corpus ID: 32145668
2012
2012
Gilenya safety update: cardiac and macula
Alison B. Huggins
,
R. Sergott
Current Opinion in Ophthalmology
2012
Corpus ID: 35745925
Review
2012
Review
2012
Fingolimod (Gilenya; FTY720): a recently approved multiple sclerosis drug based on a fungal secondary metabolite and the creation of a natural products pure compound database and organized storage…
Cherilyn R. Strader
2012
Corpus ID: 70890480
Fingolimod (Gilenya; FTY720), a synthetic compound based on the fungal secondary metabolite, myriocin (ISP-I), is a potent…
Expand
2011
2011
[A plan for risk management in the treatment of multiple sclerosis with gilenia (fingolimod)].
N. F. Popova
Zhurnal Nevrologii i Psikhiatrii imeni S.S…
2011
Corpus ID: 77264968
Review
2010
Review
2010
Oral fingolimod (gilenya) for multiple sclerosis.
The Medical letter on drugs and therapeutics
2010
Corpus ID: 40630508
2010
2010
Fingolimod (Gilenya): An oral sphingosine 1-phosphate receptor modulator
F. Staff
2010
Corpus ID: 72988176
New molecular entity: Fingolimod (Gilenya) has recently been approved by FDA to treat patients with relapsing forms of MS to…
Expand
2010
2010
FDA Actions in Brief September/October 2010 (Gilenya, Prolia, Krystexxa, Faslodex, Protopam Chloride, Ozurdex, Suboxone Film, Saphris, Tekamlo, Beyaz)
F. Staff
2010
Corpus ID: 74454223
Recent FDA Approvals (through August/September 2010) related to Gilenya, Prolia, Krystexxa, Faslodex, Protopam Chloride, Ozurdex…
Expand